Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-05

Clinical Trial Update: Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination Nebuliser Solutions in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing fixed-dose combination versus free-dose combination of ipratropium and levosalbutamol in stable COPD patients; current status unavailabl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ipratropium and Levosalbutamol Free Dose Combination Nebuliser Solutions (ipratropium and levosalbutamol free-dose combination)
  • ipratropium / levosalbutamol fixed-dose combination (ipratropium; levosalbutamol)

Snippet

Sponsor: Neutec Ar-Ge San ve Tic A.Ş | Conditions: COPD | Phase 3 | Status: UNKNOWN